Advertisement
 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Oncology

   News

 

 Conferences


   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links
   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 
 

Oncology Articles

View articles in another specialty


   

Only women at very high risk for breast cancer experience a benefit according to a study published in the journal Cancer.

Dr. Tamer Fouad, M.D.

Tuesday 25th July, 2006


A gene expression signature clearly distinguishes Burkitt lymphoma from DLBCL, a critical distinction in diagnosis.

Dr. Tamer Fouad, M.D.

Monday 12th June, 2006


Breast cancer with a certain genetic mutation can have breast-sparing surgery but should consider hormonal treatments.

Dr. Tamer Fouad, M.D.

Friday 9th June, 2006


A new test could give hospitals with limited resources an affordable way to improve the outcome of ALL treatment.

Dr. Tamer Fouad, M.D.

Friday 31st March, 2006


This trial is among the first to combine a biologic agent with a conventional chemotherapy agent for ovarian cancer.

Dr. Tamer Fouad, M.D.

Sunday 26th March, 2006


Inability to repair chromosomal damage caused by UV-B radiation increases risk of basal cell and squamous cell carcinomas.

Dr. Tamer Fouad, M.D.

Monday 16th January, 2006


A study featured in Gynecologic Oncology shows the superiority of intraperitoneal chemotherapy in advanced ovarian cancer.

Dr. Tamer Fouad, M.D.

Wednesday 11th January, 2006


Women with genetic variant that are taking tamoxifen were more likely to see their cancer return.

Dr. Tamer Fouad, M.D.

Saturday 17th December, 2005


NEJM reports that Herceptin® following standard chemotherapy significantly reduces the risk of disease recurrence.

Dr. Tamer Fouad, M.D.

Monday 24th October, 2005


The FDA has approved Pfizer's Aromasin® for adjuvant treatment of early breast cancer in postmenopausal women.

Dr. Tamer Fouad, M.D.

Wednesday 12th October, 2005


GARDASIL, an investigational vaccine shows promise in preventing cervical cancer associated with HPV infections.

Dr. Tamer Fouad, M.D.

Sunday 9th October, 2005


A Mayo Clinic study shows women with benign breast disease have a higher risk for breast cancer.

Dr. Tamer Fouad, M.D.

Monday 15th August, 2005


Study demonstrates that a drug called erlotinib (Tarceva) increases survival in patients with advanced non-small cell lung cancer.

Dr. Tamer Fouad, M.D.

Friday 15th July, 2005


SV40 does not have a role in the majority of malignant mesotheliomas according to a study in this month's Cancer Research.

Dr. Tamer Fouad, M.D.

Monday 11th April, 2005


FDA has granted full approval to DOXIL® for the treatment of ovarian cancer that has progressed or recurred after platinum-based chemotherapy.

Dr. Tamer Fouad, M.D.

Monday 21st February, 2005


Interactions between certain genetic polymorphisms and antidepressants (SSRIs) may be associated with altered tamoxifen activity.

Dr. Tamer Fouad, M.D.

Friday, 21st January 2005


A large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer showed no survival benefit from taking Iressa.

Dr. Tamer Fouad, M.D.

Wednesday, 22nd December 2004

The results suggest that almost half of those diagnosed with estrogen-dependent, lymph-node negative breast cancer may not need chemotherapy.

Dr. Tamer Fouad, M.D.

Sunday, 12th December 2004

The results suggest that those receiving more intense therapies are associated with a longer disease free survival than those receiving lower-dose therapies.

Dr. Tamer Fouad, M.D.

Monday, 28th November 2004

The results clearly indicate the efficacy of cord blood stem cells when bone marrow donors are unavailable for high risk patients.

Dr. Tamer Fouad, M.D.

Monday, 22nd November 2004

Investigators found no increase in the risk of cancer recurrence in young women with mutations that were treated with conservative surgery.

Dr. Tamer Fouad, M.D.

Monday, 22nd November 2004

In those women who completed the protocol the vaccine was 100 percent effective against persistent HPV16/18 infections.

Dr. Tamer Fouad, M.D.

Friday, 12th November 2004

Celecoxib treatment appears to exert its antiproliferative, antiangiogenic, and pro-apoptotic effects on cancer by regulating the prostaglandin pathways.

Dr. Tamer Fouad, M.D.

Wednesday, 11th November 2004

There had previously been no approved therapies for MDS. Vidaza is the first FDA approved drug for MDS.

Dr. Tamer Fouad, M.D.

Monday, 8th June 2004

Patients who underwent routine follow up with the tumor marker and CT scan enjoyed a longer survival.

Dr. Tamer Fouad, M.D.

Monday, 3rd May 2004

X-rays have been the cause of more than 5,600 cancer cases in the United States according to the study.

Dr. Tamer Fouad, M.D.

Saturday, 12th January 2004

Gefitinib is the first oral drug approved in the United States for the treatment of non-small cell lung cancer.

Jeffrey A. Gordon, M.D.


Telomerase adds nucleotides to the ends of chromosomes to compensate for losses during DNA replication.

Dr. Tamer Fouad, M.D.


Active oxygen species have long been known to be mutagenic, hence playing a role in cancer formation.


advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application



search_sm.jpg (55x55 -- 1647 bytes)
 

  Search The Doctors Lounge for more articles.

 

 advertisement.gif (61x7 -- 0 bytes)

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright © 2001-2012 DoctorsLounge®. All rights reserved.